{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:27:20Z","timestamp":1775842040908,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.091","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T10:30:00Z","timestamp":1561804200000},"page":"623-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Natural products against renin-angiotensin system for antifibrosis therapy"],"prefix":"10.1016","volume":"179","author":[{"given":"Tian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-7616","authenticated-orcid":false,"given":"Ying-Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.06.091_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2019.06.091_bib3","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","article-title":"Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches","volume":"32","author":"Unger","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2019.06.091_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrendo.2015.6","article-title":"Novel RAAS agonists and antagonists: clinical applications and controversies","volume":"11","author":"Romero","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jcsm.12334","article-title":"Angiotensin-converting enzyme 2 deficiency accelerates and angiotensin 1-7 restores age-related muscle weakness in mice","volume":"9","author":"Takeshita","year":"2018","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejmech.2019.06.091_bib6","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A\u00a0century old renin-angiotensin system still grows with endless possibilities: AT(1) receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.06.091_bib7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/2047487318780035","article-title":"Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease","volume":"25","author":"Tsujimoto","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.06.091_bib9","first-page":"956","article-title":"Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria","volume":"16","author":"Imbalzano","year":"2015","journal-title":"J.\u00a0Renin-Angio-Aldos"},{"key":"10.1016\/j.ejmech.2019.06.091_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.tips.2018.09.002","article-title":"Natural products as a source for antifibrosis therapy","volume":"39","author":"Chen","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cellsig.2018.07.011","article-title":"Balance and circumstance: the renin angiotensin system in wound healing and fibrosis","volume":"51","author":"Bernasconi","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.06.091_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.06.091_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00109-014-1211-9","article-title":"Angiotensin II stimulates canonical TGF-beta signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction","volume":"93","author":"Ehanire","year":"2015","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejmech.2019.06.091_bib14","first-page":"5","article-title":"The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis","author":"Abdul-Hafez","year":"2018","journal-title":"J.\u00a0Lung, Pulmon. Respirat. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib15","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/jcmm.13725","article-title":"Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"22","author":"Qian","year":"2018","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1681\/ASN.2010040384","article-title":"Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis","volume":"22","author":"Ruster","year":"2011","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.ejmech.2019.06.091_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/path.2721","article-title":"Essential role for smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition","volume":"221","author":"Yang","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2019.06.091_bib20","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism","volume":"111","author":"Rodriguez-Vita","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2019.06.091_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbi.2017.05.025","article-title":"Role of RAS\/Wnt\/\u03b2-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy","volume":"273","author":"Chen","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2019.06.091_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nep.13472","article-title":"New insights into the role and mechanism of Wnt\/\u03b2-catenin signalling in kidney fibrosis","volume":"23","author":"Zuo","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.ejmech.2019.06.091_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.08.045","article-title":"Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension","volume":"156","author":"Gonzalez","year":"2018","journal-title":"Biochem. Pharmaco."},{"key":"10.1016\/j.ejmech.2019.06.091_bib24","doi-asserted-by":"crossref","first-page":"F1297","DOI":"10.1152\/ajprenal.00110.2010","article-title":"The ANG-(1-7)\/ACE2\/mas axis in the regulation of nephron function","volume":"298","author":"Ferrario","year":"2010","journal-title":"Am. J. Physiol. -Renal."},{"key":"10.1016\/j.ejmech.2019.06.091_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/HJH.0000000000000094","article-title":"Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme\/Ang II axis","volume":"32","author":"Ocaranza","year":"2014","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ejmech.2019.06.091_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/CS20130449","article-title":"Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system","volume":"127","author":"Ocaranza","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejmech.2019.06.091_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2012.11.004","article-title":"Interaction between TGF-\u03b2 and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells","volume":"366","author":"Chou","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ki.2014.274","article-title":"Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade","volume":"87","author":"Zhang","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2019.06.091_bib29","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2","volume":"54","author":"Paizis","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2019.06.091_bib30","first-page":"717","article-title":"Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis","volume":"23","author":"Huang","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib31","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.v23.i19.3396","article-title":"Renin angiotensin system in liver diseases: friend or foe?","volume":"23","author":"Simoes","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib32","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.cellsig.2014.09.010","article-title":"Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1\/2","volume":"26","author":"Alzayadneh","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.06.091_bib33","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1039\/C5FO00406C","article-title":"Bioactive comparison of main components from unripe fruits of Rubus chingii Hu and identification of the effective component","volume":"6","author":"Zhang","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.ejmech.2019.06.091_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.biotechadv.2015.12.014","article-title":"Quercetin and the mitochondria: a mechanistic view","volume":"34","author":"de Oliveira","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2019.06.091_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2014.02.038","article-title":"Antihypertensive effect of caffeic acid and its analogs through dual renin-angiotensin-aldosterone system inhibition","volume":"730","author":"Bhullar","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1139\/cjpp-2012-0432","article-title":"Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat","volume":"91","author":"Li","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10557-011-6363-z","article-title":"In\u00a0vivo and in\u00a0vitro protective effects of pentamethylquercetin on cardiac hypertrophy","volume":"26","author":"He","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejmech.2019.06.091_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80305-0","article-title":"The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction","volume":"33","author":"Peres","year":"2000","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib39","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jnutbio.2014.06.003","article-title":"Beneficial effect of quercetin on cholestatic liver injury","volume":"25","author":"Lin","year":"2014","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2015.06.006","article-title":"Quercetin inhibits the mTORC1\/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy","volume":"99","author":"Lu","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib41","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3945\/jn.112.165274","article-title":"Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis","volume":"142","author":"Marcolin","year":"2012","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ejmech.2019.06.091_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jep.2009.09.059","article-title":"Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa","volume":"127","author":"Ojeda","year":"2010","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib43","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1055\/s-0032-1315198","article-title":"Blockade of the renin-angiotensin system with delphinidin, cyanin, and auercetin","volume":"78","author":"Parichatikanond","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/jf903515f","article-title":"Flavonoids from the buds of rosa damascena inhibit the activity of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and angiotensin I-converting enzyme","volume":"58","author":"Kwon","year":"2010","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/13880209.2011.608076","article-title":"Inhibitory activities of baicalin against renin and angiotensin-converting enzyme","volume":"50","author":"Deng","year":"2012","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib46","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1021\/jf3022157","article-title":"Activity-guided discovery of (S)-malic acid 1 '-O-\u03b2-gentiobioside as an angiotensin I-converting enzyme inhibitor in lettuce (lactuca sativa)","volume":"60","author":"Lagemann","year":"2012","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jep.2013.08.058","article-title":"Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats","volume":"150","author":"Lv","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ptr.2008","article-title":"Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae)","volume":"21","author":"Loizzo","year":"2007","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049493","article-title":"Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies","volume":"7","author":"Guerrero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.06.091_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/138955711795305335","article-title":"A\u00a0review on the dietary flavonoid kaempferol","volume":"11","author":"Calderon-Montano","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.04.023","article-title":"Diosmetin prevents TGF-\u03b2 1-induced epithelial-mesenchymal transition via ROS\/MAPK signaling pathways","volume":"153","author":"Ge","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2018.08.029","article-title":"Flavonoids decrease the radiation-induced increase in the activity of the angiotensin-converting enzyme in rat aorta","volume":"837","author":"Kim","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.enzmictec.2017.05.003","article-title":"Synthesis and characterization of novel astragalin galactosides using \u03b2-galactosidase from Bacillus circulans","volume":"103","author":"Han","year":"2017","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/molecules21111500","article-title":"Flavonoids-rich orthosiphon stamineus extract as new candidate for angiotensin I-converting enzyme inhibition: a molecular docking study","volume":"21","author":"Shafaei","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.06.091_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jep.2010.12.026","article-title":"Antihypertensive effects of isoquercitrin and extracts from tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme","volume":"134","author":"Gasparotto","year":"2011","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib56","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1021\/cr500716f","article-title":"Convergent strategies in total syntheses of complex terpenoids","volume":"115","author":"Urabe","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.06.091_bib57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jep.2012.09.033","article-title":"Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat","volume":"144","author":"Zhao","year":"2012","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib58","article-title":"Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.06.091_bib59","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jep.2013.10.043","article-title":"Diuretic activity of some fractions of the epidermis of Poria cocos","volume":"150","author":"Feng","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib60","first-page":"202","article-title":"Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF\/HSMS\/MSE","volume":"81\u201382","author":"Zhao","year":"2013","journal-title":"J.\u00a0Pharmaceut. Biom."},{"key":"10.1016\/j.ejmech.2019.06.091_bib61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jep.2013.04.018","article-title":"Urinary metabonomic study of the surface layer of poria cocos as an effective treatment for chronic renal injury in rats","volume":"148","author":"Zhao","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib62","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1111\/bph.14333","article-title":"Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt\/\u03b2-catenin pathway against renal fibrosis","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phymed.2018.03.034","article-title":"Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-\u03b2-mediated Smad3 phosphorylation","volume":"42","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2019.06.091_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.phymed.2017.10.008","article-title":"Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-\u03b2\/Smad signaling pathway","volume":"36","author":"Wang","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2019.06.091_bib65","first-page":"14792","article-title":"Ultrafast delivery of aggregation-induced emission nanoparticles and pure organic phosphorescent nanocrystals by saponin encapsulation","volume":"139","author":"Nicol","year":"2017","journal-title":"J.\u00a0Appl. Collab. Syst. (JACS)"},{"key":"10.1016\/j.ejmech.2019.06.091_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/etm.2012.856","article-title":"Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats","volume":"5","author":"Chen","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib67","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.biopha.2017.09.092","article-title":"Astragaloside IV protects against the pathological cardiac hypertrophy in mice","volume":"97","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.06.091_bib68","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejphar.2018.06.016","article-title":"Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome","volume":"833","author":"Wan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib69","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1159\/000486166","article-title":"Astragaloside IV prevents cardiac remodeling in the apolipoprotein E-deficient mice by regulating cardiac homeostasis and oxidative stress","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2220\/biomedres.31.155","article-title":"Inhibition of human renin activity by saponins","volume":"31","author":"Takahashi","year":"2010","journal-title":"Biomed. Res.-Tokyo"},{"key":"10.1016\/j.ejmech.2019.06.091_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1538\/expanim.16-0121","article-title":"Ginsenoside Rb1 improves cardiac function and remodeling in heart failure","volume":"66","author":"Zheng","year":"2017","journal-title":"Exp Anim Tokyo"},{"key":"10.1016\/j.ejmech.2019.06.091_bib72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/ar500454v","article-title":"Cyclohepta[b]indoles: a privileged structure motif in natural products and drug design.Biogenetically-inspired total synthesis of epidithiodiketopiperazines and related alkaloids","volume":"48","author":"Kim","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib73","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acs.accounts.6b00265","article-title":"Cyclohepta[b]indoles: a privileged structure motif in natural products and drug design","volume":"49","author":"Stempel","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1139\/Y11-006","article-title":"Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases","volume":"89","author":"Bao","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib75","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/13880209.2016.1236392","article-title":"Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-orbitrap mass spectrometer","volume":"55","author":"Cai","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2010.08.050","article-title":"Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression","volume":"213","author":"Zhou","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejmech.2019.06.091_bib77","first-page":"262","article-title":"Inhibitory effect of rutaecarpine on Thioacetamide (TAA)-induced hepatic fibrosis","volume":"20","author":"Ahn","year":"2014","journal-title":"Nat. Prod. Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib78","first-page":"22","article-title":"Synthetic fluororutaecarpine inhibits inflammatory stimuli and activates endothelial transient receptor potential vanilloid-type 1","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.06.091_bib79","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1211\/jpp.60.12.0014","article-title":"Effects of isorhynchophylline on angiotensin II-induced proliferation in rat vascular smooth muscle cells","volume":"60","author":"Zhang","year":"2008","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.phytochem.2017.12.016","article-title":"Phytochemistry and pharmacology of the genus leonurus: the herb to benefit the mothers and more","volume":"147","author":"Zhang","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.06.091_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-7843.2006.00040.x","article-title":"Matrine induces apoptosis in angiotensin U-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2\/Bax expression and caspase-3 activation","volume":"101","author":"Li","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jep.2016.05.026","article-title":"Genotoxicity and cytotoxicity of oxindole alkaloids from Uncaria tomentosa (cat's claw): chemotype relevance","volume":"189","author":"Kaiser","year":"2016","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib83","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ejps.2012.12.031","article-title":"Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2","volume":"48","author":"Shi","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib84","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1139\/apnm-2015-0145","article-title":"Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1","volume":"40","author":"Abd Allah","year":"2015","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jcmm.12175","article-title":"Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy","volume":"18","author":"Pan","year":"2014","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.trsl.2013.09.013","article-title":"Inhibitory effect of ethyl acetate extract of Aristolochia yunnanensi on cardiac fibrosis through extracellular signal-regulated kinases 1\/2 and transforming growth factor \u03b2\/small mother against decapentaplegic signaling pathways","volume":"163","author":"Shao","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib87","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/np300887d","article-title":"Extracellular signal-regulated kinases (ERK) inhibitors from aristolochia yunnanensis","volume":"76","author":"Cheng","year":"2013","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.06.091_bib88","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jep.2016.10.008","article-title":"Evaluation of anti-hypertensive activity of Ulmus wallichiana extract and fraction in SHR, DOCA-salt- and L-NAME-induced hypertensive rats","volume":"193","author":"Syed","year":"2016","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00510","article-title":"Cardioprotective effect of Ulmus wallichiana planchon in \u03b2-adrenergic agonist induced cardiac hypertrophy","volume":"7","author":"Syed","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tips.2014.02.001","article-title":"Insights into drug discovery from natural medicines using reverse pharmacokinetics","volume":"35","author":"Hao","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib91","first-page":"2047","article-title":"Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction","volume":"8","author":"Liang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejmech.2019.06.091_bib92","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1159\/000478641","article-title":"Qiliqiangxin attenuates adverse cardiac remodeling after myocardial infarction in ovariectomized mice via activation of PPAR gamma","volume":"42","author":"Shen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib93","first-page":"9","article-title":"A\u00a0metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach","volume":"8","author":"Fu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.06.091_bib94","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1159\/000443113","article-title":"Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy through downregulation of MiR-199a-5p","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib95","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7150\/ijms.18142","article-title":"Traditional Chinese medication qiliqiangxin protects against cardiac remodeling and dysfunction in spontaneously hypertensive rats","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2019.06.091_bib96","article-title":"Traditional Chinese medication qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice","volume":"5","author":"Tao","year":"2015","journal-title":"Sci Rep-UK"},{"key":"10.1016\/j.ejmech.2019.06.091_bib97","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/jcmm.12512","article-title":"Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6","volume":"19","author":"Zhou","year":"2015","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2019.06.091_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ajh.2011.219","article-title":"Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase","volume":"25","author":"Liu","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejmech.2019.06.091_bib99","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1159\/000490822","article-title":"Qiliqiangxin rescues mouse cardiac function by regulating AGTR1\/TRPV1-mediated autophagy in STZ-Induced diabetes mellitus","volume":"47","author":"Tong","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.06.091_bib100","first-page":"12","article-title":"Multipronged therapeutic effects of Chinese herbal medicine qishenyiqi in the treatment of acute myocardial infarction","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib101","article-title":"Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-kappa B signaling pathway","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.06.091_bib102","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/DDDT.S82146","article-title":"Cardioprotection against ischemia\/reperfusion injury by QiShenYiQi Pill (R) via ameliorate of multiple mitochondrial dysfunctions","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2019.06.091_bib103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jep.2015.11.023","article-title":"Qishenyiqi dropping pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation","volume":"176","author":"Wang","year":"2015","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.091_bib104","first-page":"21","article-title":"Flavonoids-rich orthosiphon stamineus extract as new candidate for angiotensin I-converting enzyme inhibition: a molecular docking study","author":"Shafaei","year":"2016","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:02:57Z","timestamp":1759327377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":104,"alternative-id":["S022352341930618X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.091","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products against renin-angiotensin system for antifibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}